Inogen | INGN - Ebit


Inogen reported $-13.83M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
AngioDynamics USD -4.05M 1.54M Feb/2025
AtriCure USD 208K 4.03M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Chart Industries USD 177.5M 8M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 242.5M 3.3M Sep/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Masimo USD 83.7M 19.2M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Orthofix International USD -18.9M 6.01M Sep/2024
Philips EUR 719M 390M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD 112.65M 44.3M Sep/2025
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025